<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36515374</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-7793</ISSN><JournalIssue CitedMedium="Internet"><Volume>601</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of physiology</Title><ISOAbbreviation>J Physiol</ISOAbbreviation></Journal><ArticleTitle>Inhibitory interneurons show early dysfunction in a SOD1 mouse model of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>647</StartPage><EndPage>667</EndPage><MedlinePgn>647-667</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1113/JP284192</ELocationID><Abstract><AbstractText>Few studies in amyotrophic lateral sclerosis (ALS) measure effects of the disease on inhibitory interneurons synapsing onto motoneurons (MNs). However, inhibitory interneurons could contribute to dysfunction, particularly if altered before MN neuropathology, and establish a long-term imbalance of inhibition/excitation. We directly assessed excitability and morphology of glycinergic (GlyT2 expressing) ventral lumbar interneurons from SOD1G93AGlyT2eGFP (SOD1) and wild-type GlyT2eGFP (WT) mice on postnatal days 6-10. Patch clamp revealed dampened excitability in SOD1 interneurons, including depolarized persistent inward currents (PICs), increased voltage and current threshold for firing action potentials, along with a marginal decrease in afterhyperpolarization duration. Primary neurites of ventral SOD1 inhibitory interneurons were larger in volume and surface area than WT. GlyT2 interneurons were then divided into three&#xa0;subgroups based on location: (1) interneurons within 100&#xa0;&#x3bc;m of the ventral white matter, where Renshaw cells (RCs) are located, (2) interneurons interspersed with MNs in lamina IX, and (3) interneurons in the intermediate ventral area including laminae VII and VIII. Ventral interneurons in the RC area were the most profoundly affected, exhibiting more depolarized PICs and larger primary neurites. Interneurons in lamina IX had depolarized PIC onset. In lamina VII-VIII, interneurons were least affected. In summary, inhibitory interneurons show very early region-specific perturbations poised to impact excitatory/inhibitory balance of MNs, modify motor output and provide early biomarkers of ALS. Therapeutics like riluzole that universally reduce CNS excitability could exacerbate the inhibitory dysfunction described here. KEY POINTS: Spinal inhibitory interneurons could contribute to amyotrophic lateral sclerosis (ALS) pathology, but their excitability has never been directly measured. We studied the excitability and morphology of glycinergic interneurons in early postnatal transgenic mice (SOD1<sup>G93A</sup> GlyT2eGFP). Interneurons were less excitable and had marginally smaller somas but larger primary neurites in SOD1&#xa0;mice. GlyT2 interneurons were analysed according to their localization within the ventral spinal cord. Interestingly, the greatest differences were observed in the most ventrally located interneurons. We conclude that inhibitory interneurons show presymptomatic changes that may contribute to excitatory/inhibitory imbalance in ALS.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. The Journal of Physiology &#xa9; 2022 The Physiological Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cavarsan</LastName><ForeName>Clarissa F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Preston R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Genry</LastName><ForeName>Landon T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reedich</LastName><ForeName>Emily J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCane</LastName><ForeName>Lynn M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaPre</LastName><ForeName>Kay J</ForeName><Initials>KJ</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puritz</LastName><ForeName>Alyssa C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manuel</LastName><ForeName>Marin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katenka</LastName><ForeName>Natallia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Computer Science and Statistics, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quinlan</LastName><ForeName>Katharina A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>George and Anne Ryan Institute for Neuroscience, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS104436</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS104436</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20GM103430</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F32 NS063535</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Physiol</MedlineTA><NlmUniqueID>0266262</NlmUniqueID><ISSNLinking>0022-3751</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013116" MajorTopicYN="N">Spinal Cord</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007395" MajorTopicYN="N">Interneurons</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">glycine</Keyword><Keyword MajorTopicYN="N">inhibition</Keyword><Keyword MajorTopicYN="N">patch clamp</Keyword><Keyword MajorTopicYN="N">renshaw cells</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>Competing interests. Authors have no competing interests/conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>14</Day><Hour>7</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36515374</ArticleId><ArticleId IdType="mid">NIHMS1858453</ArticleId><ArticleId IdType="pmc">PMC9898203</ArticleId><ArticleId IdType="doi">10.1113/JP284192</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akay T (2014) Long-term measurement of muscle denervation and locomotor behavior in individual wild-type and ALS model mice. J Neurophysiol 111:694&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pubmed">24174653</ArticleId></ArticleIdList></Reference><Reference><Citation>Allain A-E, Bairi A, Meyrand P, Branchereau P (2006) Expression of the Glycinergic System During the Course of Embryonic Development in the Mouse Spinal Cord and its Co-Localization with GABA Immunoreactivity. Journal of Comparative Neurology 496:832&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">16628621</ArticleId></ArticleIdList></Reference><Reference><Citation>Allodi I, Monta&#xf1;ana-Rosell R, Selvan R, L&#xf6;w P, Kiehn O (2021) Locomotor deficits in a mouse model of ALS are paralleled by loss of V1-interneuron connections onto fast motor neurons. Nat Commun 12:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8166981</ArticleId><ArticleId IdType="pubmed">34059686</ArticleId></ArticleIdList></Reference><Reference><Citation>Amendola J, Durand J (2008) Morphological differences between wild-type and transgenic superoxide dismutase 1 lumbar motoneurons in postnatal mice. Journal of Comparative Neurology 511:329&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">18803237</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Petropoulou O, Zis V, Sfagos C, Vassilopoulos D (2008) Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis. In Vivo (Brooklyn) 22:137&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">18396796</ArticleId></ArticleIdList></Reference><Reference><Citation>Avossa D, Grandolfo M, Mazzarol F, Zatta M, Ballerini L (2006) Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice. Neuroscience 138:1179&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">16442737</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae JS, Simon NG, Menon P, Vucic S, Kiernan C, Doyle AC, Case-book T, Holmes S (2013) The Puzzling Case of Hyperexcitability in Amyotrophic Lateral Sclerosis What Really is Hyperexcitability in ALS&#x202f;? How Can We Objectively Assess. J of clinical neurology 9:65&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3633193</ArticleId><ArticleId IdType="pubmed">23626643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellingham MC (2011) A Review of the Neural Mechanisms of Action and Clinical Efficiency of Riluzole in Treating Amyotrophic Lateral Sclerosis: What have we Learned in the Last Decade? CNS Neurosci Ther 17:4&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6493865</ArticleId><ArticleId IdType="pubmed">20236142</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, Meininger V (1994) A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis. New England Journal of Medicine 330:585&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikoff JB, Gabitto MI, Rivard AF, Drobac E, Machado TA, Miri A, Brenner-Morton S, Famojure E, Diaz C, Alvarez FJ, Mentis GZ, Jessell TM (2016) Spinal Inhibitory Interneuron Diversity Delineates Variant Motor Microcircuits. Cell 165:207&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4808435</ArticleId><ArticleId IdType="pubmed">26949184</ArticleId></ArticleIdList></Reference><Reference><Citation>Branchereau P, Martin E, Supiot L, Hodeib F, Laup&#xe9;nie A, Dalvi U, Zhu H, Cazenave W, Cattaert D (2019) Relaxation of synaptic inhibitory events as a compensatory mechanism in fetal SOD spinal motor networks. Elife 8:1&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6974356</ArticleId><ArticleId IdType="pubmed">31868588</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C, Herrando-Grabulosa M, Manzano R, Mancuso R, Osta R, Navarro X (2013) Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav 3:145&#x2013;158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3607155</ArticleId><ArticleId IdType="pubmed">23531559</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q, Martin LJ (2009a) Glycinergic Innervation of Motoneurons Is Deficient in Amyotrophic Lateral Sclerosis Mice A Quantitative Confocal Analysis. American Journal of Pathology 174:574&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2630565</ArticleId><ArticleId IdType="pubmed">19116365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang Q, Martin LJ (2009b) Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: A quantitative confocal analysis. American Journal of Pathology 174:574&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2630565</ArticleId><ArticleId IdType="pubmed">19116365</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Blizzard CA, Young KM, King AE, Dickson TC (2017) Calretinin and Neuropeptide y interneurons are differentially altered in the motor cortex of the SOD1 G93A mouse model of ALS. Sci Rep 7:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353592</ArticleId><ArticleId IdType="pubmed">28294153</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark RM, Brizuela M, Blizzard CA, Dickson TC (2018) Reduced excitability and increased neurite complexity of cortical interneurons in a familial mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 12:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6172321</ArticleId><ArticleId IdType="pubmed">30323744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumming G (2012) Understanding the new statistics: effect sizes, confidence intervals, and meta-analysis. New York: Routledge.</Citation></Reference><Reference><Citation>Delestr&#xe9;e N, Manuel M, Iglesias C, Elbasiouny SM, Heckman CJ, Zytnicki D (2014) Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. Journal of Physiology 592:1687&#x2013;1703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3979619</ArticleId><ArticleId IdType="pubmed">24445319</ArticleId></ArticleIdList></Reference><Reference><Citation>Devlin AC, Burr K, Borooah S, Foster JD, Cleary EM, Geti I, Vallier L, Shaw CE, Chandran S, Miles GB (2015) Human iPSC-derived motoneurons harbouring TARDBP or C9ORF72 ALS mutations are dysfunctional despite maintaining viability. Nat Commun 6:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4338554</ArticleId><ArticleId IdType="pubmed">25580746</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati SS, Chihi A, Wang Y, Elbasiouny SM (2016) Experimental Design and Data Analysis Issues Contribute to Inconsistent Results of C-Bouton Changes in Amyotrophic Lateral Sclerosis. eNeuro 4:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5241941</ArticleId><ArticleId IdType="pubmed">28101533</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukkipati SS, Garrett TL, Elbasiouny SM (2018) The vulnerability of spinal motoneurons and soma size plasticity in a mouse model of amyotrophic lateral sclerosis. Journal of Physiology 596:1723&#x2013;1745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5924829</ArticleId><ArticleId IdType="pubmed">29502344</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipchuk AA, Durand J (2012) Postnatal dendritic development in lumbar motoneurons in mutant superoxide dismutase 1 mouse model of amyotrophic lateral sclerosis. Neuroscience 209:144&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">22387111</ArticleId></ArticleIdList></Reference><Reference><Citation>Flynn JR, Conn VL, Boyle KA, Hughes DI, Watanabe M, Velasquez T, Goulding MD, Callister RJ, Graham BA (2017) Anatomical and molecular properties of long descending propriospinal neurons in mice. Front Neuroanat 11:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292581</ArticleId><ArticleId IdType="pubmed">28220062</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty MJ, Kanjhan R, Bellingham MC, Noakes PG (2016) Glycinergic neurotransmission: A potent regulator of embryonic motor neuron dendritic morphology and synaptic plasticity. Journal of Neuroscience 36:80&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6601792</ArticleId><ArticleId IdType="pubmed">26740651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen&#xe7; B, Jara JH, Lagrimas AKB, Pytel P, Roos RP, Mesulam MM, Geula C, Bigio EH, &#xd6;zdinler PH (2017) Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS. Sci Rep 7:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5292972</ArticleId><ArticleId IdType="pubmed">28165465</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-de-Mariscal E, Guerrero V, Sneider A, Jayatilaka H, Phillip JM, Wirtz D, Mu&#xf1;oz-Barrutia A (2021) Use of the p-values as a size-dependent function to address practical differences when analyzing large datasets. Sci Rep 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8536742</ArticleId><ArticleId IdType="pubmed">34686696</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundy D (2015) Principles and standards for reporting animal experiments in The Journal of Physiology and Experimental Physiology. J Physiol
593:2547&#x2013;2549
Available at: http://www.physoc.org/animal-experiments.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4500341</ArticleId><ArticleId IdType="pubmed">26095019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunes ZI, Kan VWY, Ye XQ, Liebscher S (2020) Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology. Front Neurosci 14:1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311855</ArticleId><ArticleId IdType="pubmed">32625051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Suga M, Satake M, Tsubaki T (1981) Reduced glycine receptor in the spinal cord in amyotrophic lateral sclerosis. Ann Neurol 9:292&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">6261674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedges L v (1981) DISTRIBUTION THEORY FOR GLASS&#x2019;S ESTIMATOR OF EFFECT SIZE AND RELATED ESTIMATORS. Journal oi Educational Statistics 6:107&#x2013;128.</Citation></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T (2007) Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28:154&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Herron LR, Miles GB (2012) GENDER-SPECIFIC PERTURBATIONS IN MODULATORY INPUTS TO MOTONEURONS IN A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS. Neuroscience 226:313&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">23000617</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossaini M, Cano SC, Van Dis V, Haasdijk ED, Hoogenraad CC, Holstege JC, Jaarsma D (2011) Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. J Neuropathol Exp Neurol 70:662&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">21760539</ArticleId></ArticleIdList></Reference><Reference><Citation>Howells J, Sangari S, Matamala JM, Kiernan MC, Marchand-Pauvert V, Burke D (2020) Interrogating interneurone function using threshold tracking of the H reflex in healthy subjects and patients with motor neurone disease. Clinical Neurophysiology 131:1986&#x2013;1996.</Citation><ArticleIdList><ArticleId IdType="pubmed">32336595</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh S, Heckman CJ, Manuel M (2021) Time course of alterations in adult spinal motoneuron properties in the SOD1(G93A) mouse model of ALS. eNeuro.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009670</ArticleId><ArticleId IdType="pubmed">33632815</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvin CW, Kim RB, Mitchell CS (2015) Seeking homeostasis: Temporal trends in respiration, oxidation, and calcium in SOD1 G93A amyotrophic lateral sclerosis mice. Front Cell Neurosci 9:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486844</ArticleId><ArticleId IdType="pubmed">26190973</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen DB, Kadlecova M, Allodi I, Meehan CF (2020) Spinal motoneurones are intrinsically more responsive in the adult G93A SOD1 mouse model of Amyotrophic Lateral Sclerosis. J Physiol.</Citation><ArticleIdList><ArticleId IdType="pubmed">32716521</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonas P, Bischofberger J, Sandk&#xfc;hler J (1998) Corelease of two fast neurotransmitters at a central synapse. Science (1979) 281:419&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">9665886</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Hughes EG, Shetty AS, Arlotta P, Goff LA, Bergles DE, Brown SP (2017) Changes in the Excitability of Neocortical Neurons in a Mouse Model of Amyotrophic Lateral Sclerosis Are Not Specific to Corticospinal Neurons and Are Modulated by Advancing Disease. The Journal of Neuroscience 37:9037&#x2013;9053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5597984</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Schonewille M, Siddique T, Schults AN, Fu R, Bar PR, Anelli R, Heckman C, Kroese AB (2004) Hyperexcitability of Cultured Spinal Motoneurons From Presymptomatic ALS Mice. J Neurophysiol 91:571&#x2013;575.</Citation><ArticleIdList><ArticleId IdType="pubmed">14523070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Siddique T, Fu R, Heckman CJ (2005) Increased persistent Na+ current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. Journal of Physiology 563:843&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1665614</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo SW, Binder MD, Heckman CJ (2020) Excessive Homeostatic Gain in Spinal Motoneurons in a Mouse Model of Amyotrophic Lateral Sclerosis. Sci Rep 10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271238</ArticleId><ArticleId IdType="pubmed">32493926</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni LM, Myles JR, Wells TL, Mayer WP, Akay T (2019) Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression. Behavioural Brain Research 369.</Citation><ArticleIdList><ArticleId IdType="pubmed">31022419</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazic SE (2010) The problem of pseudoreplication in neuroscientific studies: is it affecting your analysis?
BMC Neurosci
11:1&#x2013;17
Available at: http://www.biomedcentral.com/1471-2202/11/5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2817684</ArticleId><ArticleId IdType="pubmed">20074371</ArticleId></ArticleIdList></Reference><Reference><Citation>Leroy F, Lamotte d&#x2019;Incamps B, Imhoff-Manuel RD, Zytnicki D (2014) Early intrinsic hyperexcitability does not contribute to motoneuron degeneration in amyotrophic lateral sclerosis. Elife 3:1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4227046</ArticleId><ArticleId IdType="pubmed">25313866</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M, Lucas HC, Shmueli G (2013) Too big to fail: Large samples and the p-value problem. Information Systems Research 24:906&#x2013;917.</Citation></Reference><Reference><Citation>Malessa S, Leigh PN, Bertel O, Sluga E, Hornykiewicz O (1991) Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord. J Neurol Neurosurg Psychiatry 54:984&#x2013;988.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1014621</ArticleId><ArticleId IdType="pubmed">1686899</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Cazenave W, Cattaert D, Branchereau P (2013) Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 54:116&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">23466698</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Liu Z, Chen K, Price AC, Pan Y, Swaby JA, Golden WC (2007) Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis Mutant Superoxide Dismutase-1 Transgenic Mice: Mechanisms of Mitochondriopathy and Cell Death. Journal of Comparative Neurology 500:20&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17099894</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Silva M de L, Imhoff-Manuel RD, Sharma A, Heckman C, Shneider NA, Roselli F, Zytnicki D, Manuel M (2018) Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife 7:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5922970</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId></ArticleIdList></Reference><Reference><Citation>McGown A, McDearmid JR, Panagiotaki N, Tong H, Al Mashhadi S, Redhead N, Lyon AN, Beattie CE, Shaw PJ, Ramesh TM (2013) Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model. Ann Neurol 73:246&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608830</ArticleId><ArticleId IdType="pubmed">23281025</ArticleId></ArticleIdList></Reference><Reference><Citation>Medelin M, Rancic V, Cellot G, Laishram J, Veeraraghavan P, Rossi C, Muzio L, Sivilotti L, Ballerini L (2016) Altered development in GABA co-release shapes glycinergic synaptic currents in cultured spinal slices of the SOD1G93Amouse model of amyotrophic lateral sclerosis. Journal of Physiology 594:3827&#x2013;3840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929329</ArticleId><ArticleId IdType="pubmed">27098371</ArticleId></ArticleIdList></Reference><Reference><Citation>Milan L, Courtand G, Cardoit L, Masmejean F, Barri&#xe8;re G, Cazalets JR, Garret M, Bertrand SS (2015) Age-related changes in pre- and postsynaptic partners of the cholinergic C-boutons in wild-type and SOD1G93Alumbar motoneurons. PLoS One 10:1&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549056</ArticleId><ArticleId IdType="pubmed">26305672</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj-Dobosz I, Janik P (1999) Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Acta Neurol Scand 100:6&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">10416506</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimaru H, Sakagami H, Kakizaki M, Yanagawa Y (2011) Locomotor-related activity of GABAergic interneurons localized in the ventrolateral region in the isolated spinal cord of neonatal mice. J Neurophysiol 106:1782&#x2013;1792.</Citation><ArticleIdList><ArticleId IdType="pubmed">21734105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH, Macklis JD (2011) Corticospinal Motor Neurons and Related Subcerebral Projection Neurons Undergo Early and Specific Neurodegeneration in hSOD1G93A Transgenic ALS Mice. Journal of Neuroscience 31:4166&#x2013;4177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3643523</ArticleId><ArticleId IdType="pubmed">21411657</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zyurt MG, Topkara B, &#x130;&#x15f;ak B, T&#xfc;rker KS (2020) Amyotrophic lateral sclerosis weakens spinal recurrent inhibition and post-activation depression. Clinical Neurophysiology 131:2875&#x2013;2886.</Citation><ArticleIdList><ArticleId IdType="pubmed">33157474</ArticleId></ArticleIdList></Reference><Reference><Citation>Pambo-Pambo A, Durand J, Gueritaud J-P (2009) Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J Neurophysiol 102:3627&#x2013;3642.</Citation><ArticleIdList><ArticleId IdType="pubmed">19828728</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S, Gezelius H, Larhammar M, Hilscher MM, Lamotte d&#x2019;Incamps B, Leao KE, Kullander K (2015) Firing properties of Renshaw cells defined by Chrna2 are modulated by hyperpolarizing and small conductance ion currents Ih and ISK. European Journal of Neuroscience 41:887&#x2013;898.</Citation><ArticleIdList><ArticleId IdType="pubmed">25712471</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieri M, Carunchio I, Curcio L, Mercuri NB, Zona C (2009) Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 215:368&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">19071115</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrkiewicz M, Hausmanowa-Petrusewicz I (2011) Motoneuron afterhyperpolarisation duration in amyotrophic lateral sclerosis. Journal of Physiology 589:2745&#x2013;2754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3112552</ArticleId><ArticleId IdType="pubmed">21486815</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaitakis A, Constantakakis E (1993) Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartylglutamate in amyotrophic lateral sclerosis. Brain Res Bull 30:381&#x2013;386.</Citation><ArticleIdList><ArticleId IdType="pubmed">8457887</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen AH, Athanasiou D (2009) Increase in presynaptic territory of C-terminals on lumbar motoneurons of G93A SOD1 mice during disease progression. European Journal of Neuroscience 29:551&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">19187267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9:408&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Kajtaz E, Ciolino JD, Imhoff-Manuel RD, Tresch MC, Heckman CJ, Tysseling VM (2017) Chronic electromyograms in treadmill running SOD1 mice reveal early changes in muscle activation. Journal of Physiology 595:5387&#x2013;5400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538232</ArticleId><ArticleId IdType="pubmed">28543166</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Lamano JB, Samuels J, Heckman CJ (2015) Comparison of dendritic calcium transients in juvenile wild type and SOD1G93A mouse lumbar motoneurons. Front Cell Neurosci 9:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4392694</ArticleId><ArticleId IdType="pubmed">25914627</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ (2011) Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. Journal of Physiology 589:2245&#x2013;2260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098701</ArticleId><ArticleId IdType="pubmed">21486770</ArticleId></ArticleIdList></Reference><Reference><Citation>Raynor EM, Shefner JM (1994) Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis. Neurology 44:2148&#x2013;2153.</Citation><ArticleIdList><ArticleId IdType="pubmed">7969975</ArticleId></ArticleIdList></Reference><Reference><Citation>Restrepo CE, Lundfald L, Szab&#xf3; G, Erd&#xe9;lyi F, Zeilhofer HU, Glover JC, Kiehn O (2009) Transmitter-phenotypes of commissural interneurons in the lumbar spinal cord of newborn mice. Journal of Comparative Neurology 517:177&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pubmed">19731323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis. New England Journal of Medicine 326:1464&#x2013;1468.</Citation><ArticleIdList><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L, Viscomi MT, Caioli S, Pignataro A, Bisicchia E, Pieri M, Molinari M, Ammassari-Teule M, Zona C (2016) Altered Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic Mouse Model of Amyotrophic Lateral Sclerosis. Cerebral Cortex 26:1512&#x2013;1528.</Citation><ArticleIdList><ArticleId IdType="pubmed">25596588</ArticleId></ArticleIdList></Reference><Reference><Citation>Saba L, Viscomi MT, Martini A, Caioli S, Mercuri NB, Guatteo E, Zona C (2019) Modified age-dependent expression of NaV1.6 in an ALS model correlates with motor cortex excitability alterations. Neurobiol Dis 130:104532.</Citation><ArticleIdList><ArticleId IdType="pubmed">31302244</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangari S, Iglesias C, El Mendili MM, Benali H, Pradat PF, Marchand-Pauvert V (2016) Impairment of sensory-motor integration at spinal level in amyotrophic lateral sclerosis. Clinical Neurophysiology 127:1968&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pubmed">26971478</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S, Roselli F, Singh K, Leptien K, Julien JP, Gros-Louis F, Caroni P (2013) Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival. Neuron 80:80&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">24094105</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Logigian EL (1998) The mixed nerve silent period in normal subjects and patients with amyotrophic lateral sclerosis. Electromyogr Clin Neurophysiol 38:505&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">9842486</ArticleId></ArticleIdList></Reference><Reference><Citation>Siembab VC, Smith CA, Zagoraiou L, Berrocal MC, Mentis GZ, Alvarez FJ (2010) Target selection of proprioceptive and motor axon synapses on neonatal V1-derived Ia inhibitory interneurons and Renshaw cells. Journal of Comparative Neurology 518:4675&#x2013;4701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3038681</ArticleId><ArticleId IdType="pubmed">20963823</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, Mansfield C, Jimenez-Moreno R, Moore VDG, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C (2013) Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: Part II, results and discussion. Brain Behav 3:431&#x2013;457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SSW, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, Berry JD, Brown RH, Cudkowicz ME, Bean BP, Eggan K, Woolf CJ (2014) Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep 7:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse PJ, Wamsley JK, Zarbin MA, Price DL, Tourtellotte WW, Kuhar MJ (1983) Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptors. Ann Neurol 14:8&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">6137185</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis W, Willis JC (1964) Location of Renshaw Cells. Nature 204:1214&#x2013;1215.</Citation><ArticleIdList><ArticleId IdType="pubmed">14264395</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootz H, Fitzsimons-Kantamneni E, Larhammar M, Rotterman TM, Enjin A, Patra K, Andr&#xe9; E, Van Zundert B, Kullander K, Alvarez FJ (2013) Alterations in the motor neuron-renshaw cell circuit in the Sod1G93Amouse model. Journal of Comparative Neurology 521:1449&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3604165</ArticleId><ArticleId IdType="pubmed">23172249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Guindani M, Grieco SF, Chen L, Holmes TC, Xu X (2022) Beyond t test and ANOVA: applications of mixed-effects models for more rigorous statistical analysis in neuroscience research. Neuron 110:21&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8763600</ArticleId><ArticleId IdType="pubmed">34784504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeilhofer HU, Studler B, Arabadzisz D, Schweizer C, Ahmadi S, Layh B, B&#xf6;sl MR, Fritschy JM (2005) Glycinergic neurons expressing enhanced green fluorescent protein in bacterial artificial chromosome transgenic mice. Journal of Comparative Neurology 482:123&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">15611994</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>